Common Equity: The sum of all common equity items.
Bluejay Diagnostics, Inc. (BJDX) had Common Equity of $3.69M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-1.60M |
|
-- |
|
-- |
|
$1.62M |
|
$-1.62M |
|
$0.02M |
|
$-1.60M |
|
$-1.60M |
|
$-1.60M |
|
$-1.60M |
|
$-1.60M |
|
$-1.60M |
|
$-1.62M |
|
$-1.59M |
|
1.57M |
|
1.57M |
|
$-1.01 |
|
$-1.01 |
|
| Balance Sheet Financials | |
$3.35M |
|
$1.39M |
|
$1.54M |
|
$4.89M |
|
$1.15M |
|
-- |
|
$0.05M |
|
$1.20M |
|
|
Common Equity |
$3.69M |
$3.69M |
|
$3.69M |
|
1.64M |
|
| Cash Flow Statement Financials | |
$-4.60M |
|
-- |
|
$3.38M |
|
$4.30M |
|
$3.08M |
|
$-1.22M |
|
$-0.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.60M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-43.26% |
|
-43.26% |
|
-32.67% |
|
-43.26% |
|
$2.25 |
|
$-2.92 |
|
$-2.92 |
|